|
1
|
Hussain SK, Mu LN, Cai L, et al: Genetic
variation in immune regulation and DNA repair pathways and stomach
cancer in China. Cancer Epidemiol Biomarkers Prev. 18:2304–2309.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li C, Xia HH, Xie W, et al: Association
between interleukin-1 gene polymorphisms and Helicobacter
pylori infection in gastric carcinogenesis in a Chinese
population. J Gastroenterol Hepatol. 2:234–239. 2007. View Article : Google Scholar
|
|
3
|
Correa P: New strategies for the
prevention of gastric cancer: Helicobacter pylori and
genetic susceptibility. J Surg Oncol. 90:134–138. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Peek RM Jr and Blaser MJ: Helicobacter
pylori and gastrointestinal tract adenocarcinomas. Nat Rev
Cancer. 2:28–37. 2002. View
Article : Google Scholar
|
|
5
|
Macarthur M, Hold GL and El-Omar EM:
Inflammation and Cancer II. Role of chronic inflammation and
cytokine gene polymorphisms in the pathogenesis of gastrointestinal
malignancy. Am J Physiol Gastrointest Liver Physiol. 286:515–520.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rosenstiel P, Hellmig S, Hampe J, et al:
Influence of polymorphisms in the NOD1/CARD4 and NOD2/CARD15 genes
on the clinical outcome of Helicobacter pylori infection.
Cellular Microbiology. 8:1188–1198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hold GL, Rabkin CS, Chow WH, et al: A
functional polymorphism of toll-like receptor 4 gene increases risk
of gastric carcinoma and its precursors. Gastroenterology.
132:905–912. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Simmons DL, Botting RM and Hla T:
Cyclooxygenase isozymes: the biology of prostaglandin synthesis and
inhibition. Pharmacol Rev. 56:387–437. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sun WH, Yu Q, Shen H, et al: Roles of
Helicobacter pylori infection and cyclooxygennase-2
expression in gastric carcinogenesis. World J Gastroenterol.
10:2809–2813. 2004.PubMed/NCBI
|
|
10
|
Mrena J, Wiksten JP, Kokkola A, Nordling
S, Ristimäki A and Haglund C: COX-2 is associated with
proliferation and apoptosis markers and serves as an independent
prognostic factor in gastric cancer. Tumor Biol. 31:1–7. 2010.
View Article : Google Scholar
|
|
11
|
Zhang X, Miao X, Tan W, et al:
Identification of functional genetic variants in cyclooxygenase-2
and their association with risk of esophageal cancer.
Gastroenterology. 129:565–76. 2005.PubMed/NCBI
|
|
12
|
Szczeklik W, Sanak M and Szczeklik A:
Functional effects and gender association of COX-2 gene
polymorphism G-765C in bronchial asthma. J Allergy Clin
Immunol. 114:248–253. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu F, Pan K, Zhang X, et al: Genetic
variants in cyclooxygenase-2: expression and risk of gastric cancer
and its precursors in a Chinese population. Gastroenterology.
130:1975–1984. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sitarz R, Leguit RJ, de Leng WW, et al:
The COX-2 promoter polymorphism -765 G>C is associated
with early-onset, conventional and stump gastric cancers. Modern
Pathology. 21:685–690. 2008.
|
|
15
|
Saxena A, Prasad KN, Ghoshal UC, Bhagat
MR, Krishnani N and Husain N: Polymorphism of -765G>C
COX-2 is a risk factor for gastric adenocarcinoma and peptic
ulcer disease in addition to H. pylori infection: a study
from northern India. World J Gastroenterol. 14:1498–1503. 2008.
|
|
16
|
Tan W, Wu J, Zhang X, et al: Associations
of functional polymorphisms in cyclooxygenase-2 and platelet
12-lipoxygenase with risk of occurrence and advanced disease status
of colorectal cancer. Carcinogenesis. 28:1197–1201. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shi J, Misso NL, Kedda MA, et al:
Cyclooxygenase-2 gene polymorphisms in an Australian population:
association of the -1195G>A promoter polymorphism with mild
asthma. Clin Exp Allergy. 38:913–920. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Coskunpinar E, Eraltan IY, Turna A and
Agachan B: Cyclooxygenase-2 gene and lung carcinoma risk. Med
Oncol. View Article : Google Scholar : 2010.
|
|
19
|
Peters WH, Lacko M, te Morsche RH, Voogd
AC, Oude Ophuis MB and Manni JJ: COX-2 polymorphisms and the
risk for head and neck cancer in white patients. Head Neck.
31:938–943. 2009. View Article : Google Scholar
|
|
20
|
McCarthy CJ, Crofford LJ, Greenson J and
Scheiman JM: Cyclooxygenase-2 expression in gastric antral mucosa
before and after eradication of Helicobacter pylori infection. Am J
Gastroenterol. 94:1218–1223. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim SS, Ruiz VE, Carroll JD and Moss SF:
Helicobacter pylori in the pathogenesis of gastric cancer
and gastric lymphoma. Cancer Lett. View Article : Google Scholar : 2011.
|
|
22
|
Di JM, Pang J, Sun QP, et al: Toll-like
receptor 9 agonists up-regulates the expression of cyclooxygenase-2
via activation of NF-kappaB in prostate cancer cells. Mol Biol Rep.
37:1849–1855. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jüttner S, Cramer T, Wessler S, et al:
Helicobacter pylori stimulates host cyclooxygenase-2 gene
transcription: critical importance of MEK/ERK-dependent activation
of USF1/-2 and CREB transcription factors. Cell Microbiol.
5:821–834. 2003.
|
